Nasdaq Idya News Today

Callan Capital LLC acquired a new position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,726 shares of the company’s stock, valued at approximately $239,000. Other hedge funds have also […]

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) fell 3.2% during trading on Thursday . The company traded as low as $38.88 and last traded at $38.90. 88,103 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 847,028 shares. The stock had previously closed at $40.17. Analyst Ratings […]

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its target price upped by Citigroup from $40.00 to $60.00 in a report published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently issued reports on IDYA. Leerink Partnrs reiterated an outperform rating on shares […]

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the firm, MarketBeat.com reports. Thirteen research analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have issued ratings on the stock in the […]

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $51.00 to $57.00 in a report issued on Friday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other research analysts have also weighed in on the company. Royal Bank of Canada […]

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) shares were down 7.4% during trading on Tuesday following a weaker than expected earnings announcement. The stock traded as low as $43.61 and last traded at $43.65. Approximately 259,976 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 1,056,790 shares. […]

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) – Equities research analysts at Capital One Financial issued their FY2028 earnings estimates for shares of IDEAYA Biosciences in a research report issued on Thursday, February 22nd. Capital One Financial analyst T. Chiang forecasts that the company will earn $4.54 per share for the year. Capital One Financial […]

IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.05), Briefing.com reports. The firm had revenue of $3.90 million during the quarter, compared to the consensus estimate of $8.84 million. IDEAYA Biosciences […]

IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) had its target price lifted by research analysts at Royal Bank of Canada from $43.00 to $53.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would indicate a potential upside of 19.42% […]

IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.05), Briefing.com reports. IDEAYA Biosciences had a negative return on equity of 24.39% and a negative net margin of 439.48%. The firm had […]